Vidaza 25 mg/ml powder for suspension for injection, AG-120/S95031 250mg film-coated tablet
S095031-178
Phase 3 small_molecule active
Quick answer
Vidaza 25 mg/ml powder for suspension for injection, AG-120/S95031 250mg film-coated tablet for Hypomethylating agent (HMA) naive myelodysplastic syndromes Myelodysplastic Symdrome (MDS), Myelodysplastic Symdrome (MDS) is a Phase 3 program (small_molecule) at Institut für biomedizinische Analytik NMR-Imaging GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Institut für biomedizinische Analytik NMR-Imaging GmbH
- Indication
- Hypomethylating agent (HMA) naive myelodysplastic syndromes Myelodysplastic Symdrome (MDS), Myelodysplastic Symdrome (MDS)
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active